The neuroendocrine proteins secretogranin II and III are regionally conserved and coordinately expressed with proopiomelanocortin in Xenopus intermediate pituitary

Journal of Neurochemistry

Volumn 66, Issue 6, 1996, Pages 2248-2256

  Holthuis, Joost C M ^a   Martens, Gerard J M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Differential screening; Intermediate pituitary; Proopiomelanocortin; Secretogranin; Xenopus laevis

Indexed keywords

CHROMOGRANIN; PROOPIOMELANOCORTIN; SECRETOGRANIN II; SECRETONEURIN; SECRETORY PROTEIN;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; GENETIC CONSERVATION; GOLGI COMPLEX; HYPOPHYSIS CELL; HYPOPHYSIS INTERMEDIATE LOBE; NEUROSECRETORY CELL; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECRETION; SECRETORY GRANULE; XENOPUS;

ANIMALIA; MAMMALIA; XENOPUS LAEVIS;

EID: 0030008719     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66062248.x     Document Type: Article

References (46)

1. Agneter E., Sitte H. H., Stöckl-Hiesleitner S., Fischer-Colbrie R., Winkler H., and Singer E. A. (1995) Sustained dopamine release induced by secretoneurin in the striatum of the rat: a microdialysis study. J. Neurochem. 65, 622-625.
2. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., and Struhl K. (1989) Current Protocols in Molecular Biology. John Wiley and Sons, New York.
3. Bause E. (1983) Structural requirements of N-glycosylation of proteins. Biochem. J. 209, 331-336.
4. Benjannet S., Rondeau N., Day R., Chrétien M., and Seidah N. G. (1991) PC1 and PC2 are proprotein convertases capable of cleaving pro-opiomelanocortin at distinct pairs of basic residues. Proc. Natl. Acad. Sci. USA 88, 3564-3568.
5. Benjannet S., Savaria D., Chrétien M., and Seidah N. G. (1995) 7B2 is a specific intracellular binding protein of the prohormone convertase PC2. J. Neurochem. 64, 2303-2311.
6. Braks J. A. M. and Martens G. J. M. (1994) 7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretory pathway. Cell 78, 263-273.
7. Braks J. A. M. and Martens G. J. M. (1995) The neuroendocrine chaperone 7B2 can enhance in vitro POMC cleavage by prohormone convertase PC2. FEBS Lett. 371, 154-158.
8. Braks J. A. M., Goldenmond K. C. W., Van Riel M. C. H. M., Coenen A. J. M., and Martens G. J. M. (1992) Structure and expression of Xenopus prohormone convertase PC2. FEBS Lett. 305, 45-50.
9. Chanat E. and Huttner W. B. (1991) Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network. J. Cell Biol. 115, 1505-1519.
10. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
11. Dopazo A., Lovenberg T. W., Danielson P. E., Ottiger H.-P., and Sutcliffe J. G. (1993) Primary structure of mouse secretogranin III and its absence from deficient mice. J. Mol. Neurosci. 4, 225-233.
12. Fischer-Colbrie R., Laslop A., and Kirchmair R. (1995) Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Prog. Neurobiol. 46, 49-70.
13. Galindo E., Rill A., Bader M. F., and Aunis D. (1991) Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion. Proc. Natl. Acad. Sci. USA 88, 1426-1430.
14. Gerdes H. H., Phillips E., and Huttner W. B. (1988) The primary structure of rat secretogranin II deduced from a cDNA sequence. Nucleic Acids Res. 16, 11811.
15. Gerdes H. H., Rosa P., Phillips E., Baeuerle P. A., Frank R., Argos P., and Huttner W. B. (1989) The primary structure of human secretogranin II, a widespread tyrosine-sulfated secretory granule protein that exhibits low pH- and calcium-induced aggregation. J. Biol. Chem. 264, 12009-12015.
16. Holthuis J. C. M., Schoonderwoert V. T. G., and Martens G. J. M. (1994) A vertebrate homolog of the actin-bundling protein fascin. Biochim. Biophys. Acta 1219, 184-188.
17. Holthuis J. C. M., Jansen E. J. R., Van Riel M. C. H. M., and Martens G. J. M. (1995) Molecular probing of the secretory pathway in peptide hormone-producing cells. J. Cell Sci. 108, 3295-3305.
18. Huttner W. B. (1987) Protein tyrosine sulfation. Trends Biochem. Sci. 12, 361-363.
19. Huttner W. B. and Natori S. (1995) Helper proteins for neuroendocrine secretion. Curr. Biol. 5, 242-245.
20. Huttner W. B., Gerdes H. H., and Rosa P. (1991) The granin (chromogranin/secretogranin) family. Trends Biochem. Sci. 16, 27-30.
21. Kingsley D. M., Rinchick E. M., Russel L. B., Ottiger H.-P., Sutcliffe J. G., Copeland N. G., and Jenkins N. A. (1990) Genetic ablation of a mouse gene expressed specifically in brain. EMBO J. 9, 395-399.
22. Kirchmair R., Hogue-Angeletti R., Gutierrez J., Fischer-Colbrie R., and Winkler H. (1993) Secretoneurin - a neuropeptide generated in brain, adrenal medulla and other neuroendocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 53, 359-365.
23. Konecki D. S., Benedum U. M., Gerdes H. H., and Huttner W. B. (1987) The primary structure of human chromogranin A and pancreastatin. J. Biol. Chem. 262, 17026-17030.
24. Luzio P. J., Brake B., Banting G., Howell K. E., Braghetta P., and Stanley K. K. (1990) Identification, sequencing and expression of an integral membrane protein of the trans-Golgi network (TGN38). Biochem. J. 270, 97-102.
25. Martens G. J. M., Weterings K. A. P., Van Zoest I. D., and Jenks B. G. (1987) Physiologically-induced changes in pro-opiomelanocortin mRNA levels in the pituitary gland of the amphibian Xenopus laevis. Biochem. Biophys. Res. Commun. 143, 678-684.
26. Martens G. J. M., Bussemakers M. J. G., Ayoubi T. A. Y., and Jenks B. G. (1989) The novel pituitary polypeptide 7B2 is a highly-conserved protein coexpressed with proopiomelanocortin. Eur. J. Biochem. 181, 75-79.
27. Martens G. J. M., Braks J. A. M., Eib D. W., Zhou Y., and Lindberg I. (1994) The neuroendocrine polypeptide 7B2 is an endogenous inhibitor of the prohormone convertase PC2. Proc. Natl. Acad. Sci. USA 91, 5784-5787.
28. Ottiger H.-P., Battenberg E. F., Tsou A. P., Bloom F. E., and Sutcliffe J. G. (1990) 1B1075: a brain- and pituitary-specific mRNA that encodes a novel chromogranin/secretogranin-like component of intracellular vesicles. J. Neurosci. 10, 3135-3147.
29. Reaves B., Wilde A., and Banting G. (1992) Identification, molecular characterization and immunolocalization of an isoform of the trans-Golgi network (TGN)-specific integral membrane protein TGN38. Biochem. J. 283, 313-316.
30. Reinisch N., Kirchmair R., Kähler C. M., Hogue-Angeletti R., Fischer-Colbrie R., Winkler H., and Wiedermann C. J. (1993) Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett. 334, 41-44.
31. Rholam M., Brakch N., Germain D., Thomas D. Y., Fahy C., Boussetta H., Boileau G., and Cohen P. (1995) Role of amino acid sequences flanking dibasic cleavage sites in precursor proteolytic processing. Eur. J. Biochem. 227, 707-714.
32. Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning, A Laboratory Manual, 2nd edit. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
33. Sanger F., Nicklen S., and Coulson A. R. (1977) DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
34. Saria A., Troger J., Kirchmair R., Fischer-Colbrie R., Hogue-Angeletti R., and Winkler H. (1993) Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C). Neuroscience 54, 1-4.
35. Seidah N. G., Hendy G. N., Hamelin J., Paquin J., Lazure C., Metters K. M., Rossier J., and Chrétien M. (1987) Chromogranin A can act as a reversible processing enzyme inhibitor. FEBS Lett. 211, 144-150.
36. Sigafoos J., Chestnut W. G., Merrill B. M., Taylor L. C. E., Diliberto E. J. Jr. and Viveros O. H. (1993) Novel peptides from adrenal medullary chromaffin vesicles. J. Anat. 183, 253-264.
37. Stanley K. K. and Howell K. E. (1993) TGN38/41: a molecule on the move. Trends Cell Biol. 3, 252-255.
38. Tatemoto K., Efendic S., Mutt V., Makk G., Feistner G. J., and Barchar J. D. (1986) Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324, 476-478.
39. Thomas L., Leduc R., Thorne B., Smeekens S. P., Steiner D. F., and Thomas G. (1991) Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes. Proc. Natl. Acad. Sci. USA 88, 5297-5301.
40. Thompson M. E., Zimmer W. E., Haynes A. L., Valentine D. L., Forss-Petter S., and Scammell J. G. (1992) Prolactin granulogenesis is associated with increased secretogranin expression and aggregation in the Golgi apparatus of GH4C1 cells. Endocrinology 131, 318-326.
41. Tilemans D., Jacobs G. F. M., Andries M., Proost P., Devreese B., Van Damma J., Van Beeumen J., and Denef C. (1994) Isolation of two peptides from rat gonadotroph-conditioned medium displaying an amino acid sequence identical to fragments of secretogranin II. Peptides 15, 537-545.
42. Van Riel M. C. H. M., Tuinhof R., Roubos E. W., and Martens G. J. M. (1993) Cloning and sequence analysis of hypothalamic cDNA encoding Xenopus preproneuropeptide Y. Biochim. Biophys. Acta 190, 948-951.
43. Vaudry H. and Conlon J. M. (1991) Identification of a peptide arising the specific post-translational processing of secretogranin II. FEBS Lett. 284, 31-33.
44. Verburg-Van Kemenade B. M. L., Jenks B. G., and Driessen A. G. J. (1986) GABA and dopamine act directly on melanotropes of Xenopus to inhibit MSH secretion. Brain Res. Bull. 17, 697-704.
45. Von Heijne G. (1986) A new method for predicting signal cleavage sites. Nucleic Acids Res. 14, 4683-4690.
46. Zhu X. and Lindberg I. (1995) 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expres-sion of enzymatic activity. J. Cell Biol. 129, 1641-1650.